BSE Live
Jan 16, 16:01Prev. Close
172.45
Open Price
170.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 16, 15:58Prev. Close
172.45
Open Price
172.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
172.58 (961)
| Cash Flow of Marksans Pharma (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | -10.04 | -8.36 | 15.42 | 6.79 | 0.00 | |
| Net CashFlow From Operating Activities | 16.92 | 20.02 | 23.15 | -36.06 | 0.00 | |
| Net Cash Used In Investing Activities | -35.33 | -118.05 | -134.09 | -12.72 | 0.00 | |
| Net Cash Used From Financing Activities | 31.56 | 58.78 | 13.84 | 9.86 | 0.00 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 13.16 | -39.24 | -97.10 | -38.92 | 0.00 | |
| Cash And Cash Equivalents Begin of Year | 22.34 | 61.59 | 158.69 | 197.61 | 0.00 | |
| Cash And Cash Equivalents End Of Year | 35.50 | 22.34 | 61.59 | 158.69 | 0.00 |
26.11.2025
Marksans Pharma Consolidated September 2025 Net Sales at Rs 720.41 crore, up 12.23% Y-o-Y
24.11.2025
Marksans Pharma Standalone September 2025 Net Sales at Rs 320.44 crore, up 3.83% Y-o-Y
09.09.2025
Marksans Pharma Standalone June 2025 Net Sales at Rs 319.73 crore, up 25.62% Y-o-Y
20.05.2025
Marksans Pharma Consolidated March 2025 Net Sales at Rs 708.46 crore, up 26.51% Y-o-Y